Search by Drug Name or NDC
NDC 68462-0756-25 KETOROLAC TROMETHAMINE 30 mg/mL Details
KETOROLAC TROMETHAMINE 30 mg/mL
KETOROLAC TROMETHAMINE is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is KETOROLAC TROMETHAMINE.
MedlinePlus Drug Summary
Ketorolac is used to relieve moderately severe pain in adults, usually after surgery. Ketorolac is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
Related Packages: 68462-0756-25Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Ketorolac Injection
Product Information
| NDC | 68462-0756 |
|---|---|
| Product ID | 68462-756_ce992bee-a9f5-48bd-a00e-513f590d69f2 |
| Associated GPIs | |
| GCN Sequence Number | 039500 |
| GCN Sequence Number Description | ketorolac tromethamine VIAL 30MG/ML(1) INJECTION |
| HIC3 | S2B |
| HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
| GCN | 35239 |
| HICL Sequence Number | 005175 |
| HICL Sequence Number Description | KETOROLAC TROMETHAMINE |
| Brand/Generic | Generic |
| Proprietary Name | KETOROLAC TROMETHAMINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ketorolac tromethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/mL |
| Substance Name | KETOROLAC TROMETHAMINE |
| Labeler Name | GLENMARK PHARMACEUTICALS INC., USA |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217789 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68462-0756-25 (68462075625)
| NDC Package Code | 68462-756-25 |
|---|---|
| Billing NDC | 68462075625 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (68462-756-25) / 1 mL in 1 VIAL, SINGLE-DOSE (68462-756-01) |
| Marketing Start Date | 2023-10-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.4325 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | KETOROLAC 30 MG/ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis